163 related articles for article (PubMed ID: 26980371)
1. A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty.
Woodhouse L; Gandhi R; Warden SJ; Poiraudeau S; Myers SL; Benson CT; Hu L; Ahmad QI; Linnemeier P; Gomez EV; Benichou O;
J Frailty Aging; 2016; 5(1):62-70. PubMed ID: 26980371
[TBL] [Abstract][Full Text] [Related]
2. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.
Becker C; Lord SR; Studenski SA; Warden SJ; Fielding RA; Recknor CP; Hochberg MC; Ferrari SL; Blain H; Binder EF; Rolland Y; Poiraudeau S; Benson CT; Myers SL; Hu L; Ahmad QI; Pacuch KR; Gomez EV; Benichou O;
Lancet Diabetes Endocrinol; 2015 Dec; 3(12):948-57. PubMed ID: 26516121
[TBL] [Abstract][Full Text] [Related]
3. The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.
Sköldenberg OG; Salemyr MO; Bodén HS; Ahl TE; Adolphson PY
J Bone Joint Surg Am; 2011 Oct; 93(20):1857-64. PubMed ID: 22012522
[TBL] [Abstract][Full Text] [Related]
4. LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.
Golan T; Geva R; Richards D; Madhusudan S; Lin BK; Wang HT; Walgren RA; Stemmer SM
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):871-879. PubMed ID: 30051975
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer.
Padhi D; Higano CS; Shore ND; Sieber P; Rasmussen E; Smith MR
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1967-75. PubMed ID: 24971661
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
7. Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.
Polkey MI; Praestgaard J; Berwick A; Franssen FME; Singh D; Steiner MC; Casaburi R; Tillmann HC; Lach-Trifilieff E; Roubenoff R; Rooks DS
Am J Respir Crit Care Med; 2019 Feb; 199(3):313-320. PubMed ID: 30095981
[TBL] [Abstract][Full Text] [Related]
8. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Brown MT; Murphy FT; Radin DM; Davignon I; Smith MD; West CR
Arthritis Rheum; 2013 Jul; 65(7):1795-803. PubMed ID: 23553790
[TBL] [Abstract][Full Text] [Related]
9. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement.
Weissberger AJ; Anastasiadis AD; Sturgess I; Martin FC; Smith MA; Sönksen PH
Clin Endocrinol (Oxf); 2003 Jan; 58(1):99-107. PubMed ID: 12519419
[TBL] [Abstract][Full Text] [Related]
11. Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women.
Kenny AM; Kleppinger A; Wang Y; Prestwood KM
J Am Geriatr Soc; 2005 Nov; 53(11):1973-7. PubMed ID: 16274381
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
Rigby W; Tony HP; Oelke K; Combe B; Laster A; von Muhlen CA; Fisheleva E; Martin C; Travers H; Dummer W
Arthritis Rheum; 2012 Feb; 64(2):350-9. PubMed ID: 21905001
[TBL] [Abstract][Full Text] [Related]
14. Slower recovery after two-incision than mini-posterior-incision total hip arthroplasty. A randomized clinical trial.
Pagnano MW; Trousdale RT; Meneghini RM; Hanssen AD
J Bone Joint Surg Am; 2008 May; 90(5):1000-6. PubMed ID: 18451391
[TBL] [Abstract][Full Text] [Related]
15. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.
Papanicolaou DA; Ather SN; Zhu H; Zhou Y; Lutkiewicz J; Scott BB; Chandler J
J Nutr Health Aging; 2013; 17(6):533-43. PubMed ID: 23732550
[TBL] [Abstract][Full Text] [Related]
16. Total hip arthroplasty and perioperative oral carbohydrate treatment: a randomised, double-blind, controlled trial.
Harsten A; Hjartarson H; Toksvig-Larsen S
Eur J Anaesthesiol; 2012 Jun; 29(6):271-4. PubMed ID: 22450530
[TBL] [Abstract][Full Text] [Related]
17. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee.
Rampersaud YR; Ravi B; Lewis SJ; Stas V; Barron R; Davey R; Mahomed N
Spine J; 2008; 8(2):296-304. PubMed ID: 17669690
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. A specific inpatient aquatic physiotherapy program improves strength after total hip or knee replacement surgery: a randomized controlled trial.
Rahmann AE; Brauer SG; Nitz JC
Arch Phys Med Rehabil; 2009 May; 90(5):745-55. PubMed ID: 19406293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
